OmniAb, Inc.'s revenue has shrunk 17% a year over three years. Revenue growth, 3-year annual rate: −17% (Biotechnology median +21%). Years of annual history on file: 5, FY2021 to FY2025, as filed.

OABIOmniAb, Inc.

Healthcare

$4.66+182% 1Y

$4.66

$1.3652 weeks$5.03

Is it growing?

Good

Growing: revenue growing +67% year on year and operating margin widening (+97.1 points).

2 good, 1 without data

Revenue trend+67% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+97.1 points operating

Trailing-twelve-month operating margin, -275.5% now against -372.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.